Veterinary sanitary assessment of mutton after application of antihelminth feed additive with albendazole

Abstract This study assessed the anthelminthic feed additive albendazole effect on the main indicators of the quality of sheep meat obtained from infected and deworming animals. A total of 20 heads of Akzhaik meat and wool sheep (i.e. 2 years of age, of different sex) were used in a 20-day experiment and 2 groups of 10 heads were formed (n = 4). The sheep were fed with the basic diet (i.e. control, group CON), without adding anything, and the second group was fed the basic diet orally with the addition of a dose of 1.2 g / head (an experimental group). At the end of the experiment, a control slaughter was carried out from each group in order to study the biochemical composition of meat and its quality. The anthelmintic feed additive albendazole did not have a significant effect on the indicators (organoleptic and physicochemical) of meat quality (P> 0.04). However, the ratio of fat and ash in the meat of the control group has differences in indicators and is reduced by 24.81% and 0.03%, respectively. The drug had a significant effect on the biological value of meat in the experimental group, where there is a higher content of essential amino acids (P = 0.06), nonessential (P = 0.05) concentrations in comparison with the CON groups. The results obtained show that the meat of the experimental groups of sheep, when using the anthelminthic feed additive albendazole, did not have a significant effect on organoleptic parameters, but significantly positively influenced the metabolism, live weight gain and biological value of meat.

Resumo Este estudo avaliou o efeito do aditivo anti-helmíntico albendazol sobre os principais indicadores de qualidade da carne ovina obtida de animais infectados e desparasitados. Um total de 20 cabeças de carne Akzhaik e ovelhas de lã (ou seja, 2 anos de idade, de sexo diferente) foi usado em um experimento de 20 dias e dois grupos de 10 cabeças foram formados (n = 4). As ovelhas foram alimentadas com dieta básica (ou seja, controle, grupo CON), sem adicionar nada, e o segundo grupo foi alimentado com dieta básica por via oral com a adição de uma dose de 1,2 g / cabeça (um grupo experimental). Ao final do experimento, foi realizado um abate controle de cada grupo para estudar a composição bioquímica da carne e sua qualidade. O aditivo anti-helmíntico albendazol não teve efeito significativo sobre os indicadores (organolépticos e físico-químicos) de qualidade da carne (P > 0,04). No entanto, a proporção de gordura e cinzas na carne do grupo de controle tem diferenças nos indicadores e é reduzida em 24,81% e 0,03%, respectivamente. A droga teve efeito significativo sobre o valor biológico da carne no grupo experimental, onde há maior teor de aminoácidos essenciais (P = 0,06), concentrações não essenciais (P = 0,05) em comparação com os grupos CON. Os resultados obtidos mostram que a carne dos grupos experimentais de ovinos, ao utilizar o aditivo anti-helmíntico albendazol, não teve efeito significativo nos parâmetros organolépticos, mas influenciou positivamente de forma significativa no metabolismo, ganho de peso vivo e valor biológico da carne.

Veterinary sanitary assessment of mutton after application of antihelminth feed additive with albendazole / Avaliação sanitária veterinária de carneiro após aplicação de aditivo anti-helmíntico com albendazol

Abstract This study assessed the anthelminthic feed additive albendazole effect on the main indicators of the quality of sheep meat obtained from infected and deworming animals. A total of 20 heads of Akzhaik meat and wool sheep (i.e. 2 years of age, of different sex) were used in a 20-day experiment and 2 groups of 10 heads were formed (n = 4). The sheep were fed with the basic diet (i.e. control, group CON), without adding anything, and the second group was fed the basic diet orally with the addition of a dose of 1.2 g / head (an experimental group). At the end of the experiment, a control slaughter was carried out from each group in order to study the biochemical composition of meat and its quality. The anthelmintic feed additive albendazole did not have a significant effect on the indicators (organoleptic and physicochemical) of meat quality (P> 0.04). However, the ratio of fat and ash in the meat of the control group has differences in indicators and is reduced by 24.81% and 0.03%, respectively. The drug had a significant effect on the biological value of meat in the experimental group, where there is a higher content of essential amino acids (P = 0.06), nonessential (P = 0.05) concentrations in comparison with the CON groups. The results obtained show that the meat of the experimental groups of sheep, when using the anthelminthic feed additive albendazole, did not have a significant effect on organoleptic parameters, but significantly positively influenced the metabolism, live weight gain and biological value of meat.

Resumo Este estudo avaliou o efeito do aditivo anti-helmíntico albendazol sobre os principais indicadores de qualidade da carne ovina obtida de animais infectados e desparasitados. Um total de 20 cabeças de carne Akzhaik e ovelhas de lã (ou seja, 2 anos de idade, de sexo diferente) foi usado em um experimento de 20 dias e dois grupos de 10 cabeças foram formados (n = 4). As ovelhas foram alimentadas com dieta básica (ou seja, controle, grupo CON), sem adicionar nada, e o segundo grupo foi alimentado com dieta básica por via oral com a adição de uma dose de 1,2 g / cabeça (um grupo experimental). Ao final do experimento, foi realizado um abate controle de cada grupo para estudar a composição bioquímica da carne e sua qualidade. O aditivo anti-helmíntico albendazol não teve efeito significativo sobre os indicadores (organolépticos e físico-químicos) de qualidade da carne (P > 0,04). No entanto, a proporção de gordura e cinzas na carne do grupo de controle tem diferenças nos indicadores e é reduzida em 24,81% e 0,03%, respectivamente. A droga teve efeito significativo sobre o valor biológico da carne no grupo experimental, onde há maior teor de aminoácidos essenciais (P = 0,06), concentrações não essenciais (P = 0,05) em comparação com os grupos CON. Os resultados obtidos mostram que a carne dos grupos experimentais de ovinos, ao utilizar o aditivo anti-helmíntico albendazol, não teve efeito significativo nos parâmetros organolépticos, mas influenciou positivamente de forma significativa no metabolismo, ganho de peso vivo e valor biológico da carne.

Mielopatía dorsal aguda como presentación atípica de una neurocisticercosis espinal

La neurocisticercosis espinal es una enfermedad infecciosa poco frecuente. Su presentación puede ser extraespinal o intraespinal y la mayoría de casos es de evolución subaguda o crónica. Se presenta el caso de una paciente mujer de 55 años, natural y procedente de Lima, Perú, con cuadro clínico de una paraparesia aguda secundaria a una mielopatía dorsal por lesiones quísticas de cisticercosis espinal. La paciente recibió tratamiento médico y quirúrgico con una evolución clínica y de imágenes favorable. Es importante considerar en nuestro contexto epidemiológico, la cisticercosis espinal como diagnóstico diferencial, ante un cuadro clínico de mielopatía aguda, ya que el adecuado enfoque diagnóstico y tratamiento oportuno de esta rara entidad pueden mejorar el pronóstico de los pacientes.

Spinal neurocysticercosis is an infectious and rare disease. Its presentation can be extraspinal or intraspinal and most cases are of subacute or chronic evolution. We report the case of a 55-year-old female patient from Lima, Peru with a 2-day history of acute paraparesis secondary to dorsal myelopathy due to cystic lesions of spinal cysticercosis. The patient received medical and surgical treatment with a favorable clinical and imaging evolution. In our epidemiological context, it is important to consider a spinal cysticercosis as a differential diagnosis when faced with a clinical picture of acute myelopathy, since the appropriate diagnostic approach and timely treatment of this rare entity can improve the prognosis of patients.

Update on the diagnosis and management of neurocysticercosis / Atualização no diagnóstico e manejo da neurocisticercose

ABSTRACT Background: Neurocysticercosis (NCC) is a serious public health problem in several developing countries, including those in Latin America, Asia, and Africa. NCC is considered to be the main cause of late-onset epilepsy in endemic areas. Objective: This review summarizes recent advances in diagnosis and therapy of NCC. Methods: Relevant articles and books were reviewed and used as a source of information for this review. Results: The diagnosis of NCC is based upon neuroimaging studies (MRI and computed tomography) and laboratory analysis of the cerebrospinal fluid (CSF). Praziquantel and albendazole are considered parasiticidal drugs against NCC, but there is an intense debate over the value and safety of these drugs. Conclusion: Given the relative scarcity of clinical trials, more comparative interventional studies, especially randomized controlled trials in long-term clinical evolution, are required in order to clarify the controversy over the validity of parasitic therapy in patients with NCC.

RESUMO Antecedentes: A neurocisticercose (NCC) é grave problema de saúde pública nos países em desenvolvimento, especialmente na América Latina, Ásia e África. A NCC é considerada a principal causa de epilepsia de início tardio nas regiões endêmicas. Objetivo: Este artigo pretende discutir os recentes avanços no diagnóstico e tratamento da NCC. Métodos: Artigos científicos e livros relevantes serviram de fonte de informação para esta revisão. Resultados: O diagnóstico da NCC é fundamentado nos exames de neuroimagem (ressonância magnética e tomografia computadorizada) e do líquido cefalorraquiano (LCR). Atualmente, praziquantel e albendazole são considerados eficazes na terapêutica etiológica da NCC, mas há intenso debate quanto à validade e segurança desses medicamentos. Conclusão: Pela relativa carência de ensaios clínicos, são necessários novos estudos particularmente randomizados, controlados e com análise de desfechos clínicos a longo prazo para o esclarecimento da polêmica envolvendo a validade da terapêutica parasiticida na NCC.

[Alveolar echinococcosis (fox tapeworm)-a surprising diagnosis in a patient with epididymal tumor]. / Echinococcosis alveolaris (Fuchsbandwurmerkrankung) ­ eine überraschende Diagnose bei Nebenhodentumor.

Alveolar ecchinococcosis, caused by the fox tapeworm (echinococcosus multilocularis), is in principle a lethal illness. We report on a 31-year-old man presenting with an unclear epididymal tumor, in whom further examinations revealed multiple and extended partially cystic, partially solid intra-abdominal tumors. Diagnosis was achieved histologically by percutaneous biopsy of a spleen lesion and serologically. As a surgical resection of the lesions was not feasible, therapy with albendazol was initiated.

Brain lesions associated with eosinophilia. A useful clue for neurotoxocariasis. Report of one case

ABSTRACT Neurotoxocariasis is uncommon. Its manifestations include events of meningitis, encephalitis and less frequently vasculitis, which manifest as headache, seizures, focalization, confusion, cognitive alterations and /or fever. Peripheral eosinophilia with clinical and neurological imaging elements, allow its early suspicion. We report a 48-year-old agricultural worker, admitted in our hospital for one week of gastrointestinal complaints, headache, progressive left hemiparesis and impaired consciousness. He had leukocytosis (13,530/μL) with peripheral eosinophilia (25%, absolute count 3,400 /μL). CSF analysis revealed no abnormalities and brain CT showed poorly defined hypodense lesions on subcortical areas and semioval centers. Magnetic resonance imaging showed multiple foci with increased signals predominantly in the white matter in both hemispheres, especially at frontal and occipital regions and at semioval centers. Lesions reinforced after paramagnetic contrast. Serological studies found specific IgG antibodies by ELISA against antigens of the genus Toxocara, which were confirmed by a positive IgG Western Blot. The patient was treated with albendazole (800 mg/d) for 14 days associated with parenteral and then oral corticosteroids with a favorable response and gradual complete recovery.

La neurotoxocariasis es infrecuente. Sus manifestaciones incluyen eventos de meningitis, encefalitis y con menor frecuencia vasculitis, que se manifiestan como cefalea, convulsiones, focalización, confusión, alteraciones cognitivas o fiebre. La eosinofilia periférica, junto a elementos clínicos e imágenes compatibles, permiten su sospecha. Informamos el caso de un trabajador agrícola de 48 años que ingresó por una semana de molestias gastrointestinales, cefalea, hemiparesia izquierda progresiva y deterioro de conciencia. Los exámenes revelaron leucocitosis (13.530/μL) con eosinofilia periférica (25%, recuento absoluto 3.400/μL). El análisis del LCR sin anomalías y la tomografía computada cerebral mostró lesiones hipodensas mal definidas en áreas subcorticales y centros semiovales. La resonancia magnética mostró múltiples focos con aumento de la señal predominantemente en la sustancia blanca en ambos hemisferios. Las lesiones presentaron refuerzo tras contraste paramagnético. Los estudios serológicos indicaron anticuerpos IgG específicos por ELISA contra antígenos del género Toxocara. El paciente fue tratado con albendazol (800 mg /día) durante 14 días asociado a corticoides con respuesta favorable y una recuperación gradual completa.

Punica granatum and amygdalin extracts plus cobalamin combined with albendazole reduce larval burden and myositis in experimental trichinosis / Extratos de Punica granatum e amígdalina mais cobalamina combinado com albendazol reduzem a carga larvar e a miosite na triquinose experimental

Abstract Trichinellosis is a zoonosis results from eating raw or semi-cooked meat of infected animals. Medicinal plants have been used lately as alternatives and/or combined therapies to resolve some drawbacks of the current regimens. This work analyzed the effect of albendazole monotherapy on Trichinella spiralis experimental infection (group A), in comparison to P. granatum and amygdalin extracts +cobalamin (group B), plus its combination with albendazole (group C). The study revealed that the extracts alone or combined with albendazole had an inferior effect to albendazole monotherapy regarding number of adult worms (40.83 ±3.82, 18.67 ±1.86 and 16.83 ±2.32, respectively). However, their effect was more obvious in muscle phase combined with albendazole, achieving the lower number of larvae/mL tissue homogenate (22.33 ±3.27 in comparison to 39.67 ±2.58 achieved by albendazole monotherapy). The extracts exerted a significant immunomodulatory effect by reducing the local CD4+ expression in the intestine as well as in muscle phase (1.15 ±0.25 and 3.80 ±0.65 in comparison to 4.97 ±0.37 and 12.20 ±0.87 with albendazole monotherapy, respectively). So, these extracts improved the therapeutic efficacy of albendazole, specifically in muscle phase and counteracted the inflammatory reaction caused by albendazole monotherapy, thus extensively alleviating the resulting myositis.

Resumo Trichinellosis é uma zoonose resultante da ingestão de carne crua ou semicozida de animais infectados. As plantas medicinais têm sido usadas, ultimamente, como alternativas e/ou terapias combinadas, para resolver algumas desvantagens dos regimes atuais. Este trabalho analisou o efeito da monoterapia albendazole na infecção experimental por Trichinella spiralis (grupo A), em comparação com extratos de P. granatum e amígdalina +cobalamina (grupo B), além de sua combinação com albendazol (grupo C). O estudo revelou que os extratos sozinho ou combinado com albendazol teve efeito inferior à monoterapia albendazol em relação ao número de vermes adultos (40,83 ±3,82, 18,67 ±1,86 e 16,83 ±2,32, respectivamente). No entanto, seu efeito foi mais óbvio na fase muscular combinado com o albendazol, alcançando o menor número de larvas/mL homogeneizado de tecido (22,33 ±3,27 em comparação com 39,67 ±2,58 obtidos pela monoterapia albendazol). Os extratos exerceram um efeito imunomodulatório significativo, ao reduzir a expressão local CD4+ no intestino, bem como na fase muscular (1,15 ±0,25 e 3,80 ±0,65 em comparação com 4,97 ±0,37 e 12,20 ±0,87 com monoterapia albendazol, respectivamente). Assim, esses extratos melhoraram a eficácia terapêutica do albendazol, especificamente na fase muscular e neutralizaram a reação inflamatória causada pela monoterapia albendazol, aliviando extensivamente a miosite resultante.

Tratamento farmacológico da estrongiloidíase em pacientes transplantados / Pharmacological treatment of strongilloidiasis in transplanted patients

O objetivo deste artigo foi comparar o uso da ivermectina e do albendazol em pacientes transplantados e relatar os respectivos sucessos terapêuticos nessa população. Foram analisados artigos que abordassem relatos de casos publicados nos últimos 4 anos no PubMed® relacionando os descritores "transplante de órgãos", "estrongiloidíase" e "tratamento". Foram encontrados e analisados dez relatos de caso que abordaram a estrongiloidíase em situa- ção pós-transplante contemplando 13 indivíduos. Desses, cinco (38,5%) utilizaram ambos os medicamentos, dos quais quatro (80%) se curaram, tendo recebido albendazol e ivermectina por via subcutânea (50%) ou albendazol e ivermectina por vias oral/ subcutânea (50%). O paciente que morreu recebeu albendazol e ivermectina por via subcutânea. Sete (53,8%) indivíduos utiliza- ram apenas ivermectina, dos quais três (42,8%) se curaram tendo recebido o medicamento oral (dois pacientes) ou subcutâneo (um paciente); dois (28,6%) morreram recebendo o medicamento via oral, dois (28,6%) usaram profilaticamente via oral e apenas um não manifestou sintomas. Apenas um (7,7%) indivíduo utilizou somente albendazol via oral tendo sobrevivido à infecção. A uti- lização combinada dos medicamentos ivermectina e albendazol parece ter efeito positivo no tratamento da estrongiloidíase. A administração da ivermectina por via subcutânea apresentou resultados promissores, contudo estudos controlados de siner- gia medicamentosa e vias de administração devem ser realizados para efetiva avaliação.

The objective of this article was to compare the use of ivermec- tin and albendazole in transplanted patients and to report the respective therapeutic successes in this population.Articles ad- dressing case reports published in the last 4 years in the PubMed relating the descriptors "organ transplantation", "strongyloidia- sis", and "treatment" were analyzed. Ten case reports addres- sing strongyloidiasis in a post-transplant situation, covering 13 individuals, were found and analyzed. Of these, five (38.5%) used both drugs of which 4 (80%) were cured having received subcu- taneous albendazole and ivermectin (50%) or oral/subcutaneous albendazole and ivermectin (50%). The patient who died received subcutaneous albenzadole and ivermectin. Seven (53.8%) indi- viduals used only ivermectin, of which three (42.8%) were cured having received the oral (2/3) or subcutaneous (1/3) medication, two (28.6%) died receiving the oral medication, and two (28.6%) used oral medication prophylactically, and only one did not show symptoms. Only one (7.7%) individual used only oral albenzadole and survived the infection. The combined use of the drugs iver- mectin and albendazole seems to have a positive effect on the treatment of strongyloidiasis. The administration of subcuta- neous Ivermectin has shown promising results; however, con- trolled studies of drug synergy and administration routes shall be performed for effective evaluation.

COVID-19: The Ivermectin African Enigma / COVID-19: El enigma de la Ivermectina en Africa

Abstract Introduction: The low frequency of cases and deaths from the SARS-CoV-2 COVID-19 virus in some countries of Africa has called our attention about the unusual behavior of this disease. The ivermectin is considered a drug of choice for various parasitic and viral diseases and shown to have in vitro effects against SARS-CoV-2. Aims: Our study aimed to describe SARS-CoV2 infection and death rates in African countries that participated in an intensive Ivermectin mass campaign carried out to control onchocerciasis and compare them with those of countries that did not participate. Methods: Data from 19 countries that participated in the World Health Organization (WHO) sponsored African Programme for Onchocerciasis Control (APOC), from 1995 until 2015, were compared with thirty-five (Non-APOC), countries that were not included. Information was obtained from https://www.worldometers.info/coronavirus/ database. Generalized Poisson regression models were used to obtain estimates of the effect of APOC status on cumulative SARS-CoV-2 infection and mortality rates. Results: After controlling for different factors, including the Human Development Index (HDI), APOC countries (vs. non-APOC), show 28% lower mortality (0.72; 95% CI: 0.67-0.78) and 8% lower rate of infection (0.92; 95% CI: 0.91-0.93) due to COVID-19. Conclusions: The incidence in mortality rates and number of cases is significantly lower among the APOC countries compared to non-APOC countries. That a mass public health preventive campaign against COVID-19 may have taken place, inadvertently, in some African countries with massive community ivermectin use is an attractive hypothesis. Additional studies are needed to confirm it.

Resumen Introducción: La baja frecuencia de casos y muertes por el virus SARS-CoV-2 COVID-19 en algunos países de África llamó nuestra atención sobre el comportamiento inusual de esta enfermedad. La ivermectina se considera un fármaco de elección para diversas enfermedades parasitarias y virales, y se ha demostrado que tiene efectos in vitro contra el SARS-CoV-2. Objetivos: Nuestro estudio tiene el objetivo describir las tasas de infección y mortalidad del SARS-CoV-2 en los países africanos que participaron en una campaña intensiva masiva de ivermectina para el control de la oncocercosis y compararlas con las de los países que no participaron. Métodos: Los datos de 19 países que participaron en el Programa Africano para el Control de la Oncocercosis (APOC) patrocinado por la Organización Mundial de la Salud (OMS), desde 1995 hasta 2015, se compararon con 35 países que no fueron incluidos (NO APOC). La información sobre casos y muertes por COVID-19 se obtuvo de la base de datos https://www.worldometers.info/coronavirus/. Se utilizaron modelos de regresión de Poisson para obtener estimaciones del efecto del estado APOC sobre las tasas acumuladas de infección y mortalidad por SARS-CoV-2. Resultados: Después de controlar diferentes factores, incluido el Índice de Desarrollo Humano (IDH), los países APOC (frente a los no APOC) mostraron una mortalidad 28% menor (razón de tasas ajustada: RR= 0.72, IC 95%: 0.67-0.78) y una tasa de infección 8% menor (RR= 0.92, IC 95%: 0.91-0.93) por COVID-19. Conclusiones: Las tasas de mortalidad e infección son significativamente más bajas en países APOC en comparación con los países no APOC. Una campaña preventiva masiva de salud pública contra el COVID-19 pudo haber tenido lugar inadvertidamente en algunos países africanos con un uso masivo de ivermectina en la comunidad es una hipótesis atractiva. Se necesitan estudios adicionales para confirmarlo.

Baja prevalencia de Enterobius vermicularis en niños de los "Centros infantiles del Buen Vivir" Cantón Jipijapa, Ecuador / Low prevalence of Enterobius vermicularis in children of "Centros infantiles del Buen Vivir" Canton Jipijapa, Ecuador

Enterobius vermicularis es un helminto que afecta principalmente a niños. El objetivo del estudio fue determinar la prevalencia de E. vermicularis en 70 preescolares de Jipijapa, Ecuador. Se identificó un solo niño con el helminto; esto puede atribuirse al tratamiento con Albendazol que los niños escolarizados reciben regularmente en el país

Enterobius vermicularis, is a helminth that mainly affects children. The objective of the study was to determine the prevalence of E. vermicularis in 70 preschoolers in Jipijapa, Ecuador. A single child was identified with the helminth; this can be attributed to the Albendazole treatment that school children receive regularly in the country

Gastrointestinal nematode infections do not hinder the development of Simmental X Nellore crossbred calves raised with a nutritionally enhanced diet / Infecções por nematódeos gastrintestinais não prejudicam o desenvolvimento de bezerros Simental x Nelore criados em plano nutricional elevado

Abstract An evaluation was made of the effect of anthelmintic treatments on the performance of Simmental X Nellore crossbred calves before and after weaning. To this end, the calves were divided into three groups: (1) treated monthly with a low efficacy anthelmintic drug, ivermectin; (2) treated monthly with a highly effective anthelmintic drug, albendazole; and (3) untreated control group. All the groups in this experiment showed an average fecal egg count of less than 400 eggs per gram (EPG), and no clinical signs of parasitic gastroenteritis. The blood variables were within the normal range and no calf presented anemia. In most of the samplings, mean EPGs were significantly lower (P<0.05) in the group treated with albendazole. The calves received dietary supplementation before and after weaning, which enabled them to gain weight in every month of the experiment and reach a body weight of about 250 kg on the last sampling date, before turning one year old. The anthelmintic treatments did not affect body weight gain, leading to the conclusion that, when fed with suitable dietary supplements, Simmental X Nellore crossbred calves are not affected by gastrointestinal nematode parasites acquired by grazing.

Resumo O objetivo do experimento foi avaliar o efeito de tratamentos anti-helmínticos no desempenho de bezerros Simental x Nelore antes e após o desmame. Os bezerros foram alocados em três grupos: (1) tratado mensalmente com anti-helmínticos de baixa eficácia, ivermectina; (2) tratado mensalmente com anti-helmíntico de alta eficácia, albendazol e (3) controle não tratado. A média das contagens de ovos de nematoides durante o experimento foi inferior a 400 ovos por grama (OPG) em todos os grupos sem manifestação clínica de gastroenterite parasitária. As variáveis ​​sanguíneas mantiveram-se dentro dos limites de normalidade e nenhum bezerro apresentou anemia. Na maioria das coletas, as médias de OPG foram significativamente inferiores (P<0,05) no grupo tratado com albendazol. Os bezerros receberam suplementação antes e depois do desmame, o que lhes permitiu ganhar peso em todos os meses do experimento, atingindo peso corporal em torno de 250 kg, ao final do experimento, antes de completarem um ano de idade. Não houve efeito dos tratamentos anti-helmínticos no ganho em peso, o que permitiu concluir que bezerros Nelore x Simental não são afetados pelo parasitismo por nematoides gastrintestinais sob condições de pastejo, quando devidamente suplementados com concentrado.

Microscopic alterations in Fasciola hepatica from sheep treated with albendazole / Alterações microscópicas em Fasciola hepatica de ovelhas tratadas com albendazol

Abstract Currently, albendazole is one of the most commonly used drugs because of its affordability. The objective was to evaluate the histopathology of Fasciola hepatica specimens. For this, the efficacy test was performed on sheep treated with albendazole at the dose recommended for F. hepatica, in which the helminths recovered at necropsy were counted and separated for histology. Spermatogenic cells from parasites recovered from treated and control sheep were examined by microscopy. The fecal egg-count reduction test revealed 97.06% efficacy of albendazole in the treatment of F. hepatica. Changes in testicular tubule cells started 48 hours after treatment and became evident within 72 hours, at which point it became difficult to identify cell types. Primary and secondary spermatogonia became increasingly rare and intercellular vacuolization was more evident. Signs of apoptosis, with pycnotic nuclei and evidence of keriorrexia were observed at all times. Cell debris was identified 96 hours after treatment. The results indicated that parasitic spermatogenesis was severely affected by albendazole and demonstrated the importance of the use of histopathology for the diagnosis of therapeutic efficacy in field strains.

Resumo Na atualidade, o albendazol é uma das drogas mais usadas devido à sua acessibilidade econômica. O objetivo foi avaliar a histopatologia dos espécimes de Fasciola hepatica. Para isso, foi realizado o teste de eficácia em ovinos tratados com albendazol na dose recomendada para Fasciola hepatica, no qual os helmintos recuperados em necropsia foram contabilizados e separados para histologia. As células espermatogênicas de parasitas recuperados de ovinos tratados e controle foram examinadas por microscopia. O teste de redução de ovos por grama de fezes revelou 97,06% de eficácia do albendazol no tratamento de F. hepatica. As alterações nas células dos túbulos testiculares iniciaram-se 48 horas após o tratamento e tornaram-se evidentes em 72 horas, altura em que tornou-se difícil identificar os tipos de células. As espermatogônias primárias e secundárias tornaram-se cada vez mais raras e a vacuolização intercelular foi mais evidente. Sinais de apoptose, com núcleos picnóticos e evidência de cariorrexia foram observados em todos os momentos. Os detritos celulares foram identificados 96 horas após o tratamento. Os resultados indicaram que a espermatogênese parasitária foi severamente afetada pelo albendazol e demonstrou a importância do uso da histopatologia para o diagnóstico de eficácia terapêutica em cepas de campo.

Quiste hidatídico pulmonar en paciente con diagnóstico de asma bronquial, a propósito de un caso / Hydatidpulmonary cyst in a patient with a diagnosis of bronchial asthma, on a case

La hidatidosis es una zoonosis distribuida mundialmente, causada por el Echinococcus granulosusen su fase larvaria. Prevalente en zonas agrícolas y ganaderas, su localización más habitual es hepática y pulmonar (>90 %), puede ser asintomática o manifestar síntomas de acuerdo con el órgano afecto o a la presencia de complicaciones. Es poco frecuente, siendo principalmente diagnosticada de manera incidental en estudios radiológicos de rutina. En Ecuador la incidencia de enfermedad hidatídica es baja a pesar de las condiciones epidemiológicas idóneas para el crecimiento del equinococo, en comparación con los países vecinos, donde la incidencia de esta enfermedad es superior, sin embargo, podrían faltar estudios que aporten datos estadísticos exactos que orienten hacia una realidad epidemiológica más clara de esta patología en el país.

Hydatidosis it's a worldwide distributed zoonosis, caused by the larval stage of Echinococcus granulosus. Prevalent in agricultural and livestock zones, the most common location is liver and lung (> 90 %), it can be asymptomatic or causing symptoms according with the injured organ or development of complications. Seems to be a rare condition, been in most cases incidentally diagnosed on a routine x-ray evaluation. Hydatid disease incidence in Ecuador is very low despite the epidemiological conditions suitable for the growth of Echinococcus, in comparison with neighboring countries where the incidence of this disease is higher. However, more studies could be needed to provide accurate statistics data than approach a clearer epidemiological reality of this disease in the country.

Neurocisticercosis, Epilepsia Y Uso De Drogas Antiparasitarias / Neurocysticercosis, Epilepsy And The Use Of Antiparasitic Drugs

RESUMEN Las drogas cisticidas se han usado por más de tres décadas. Sin embargo, su eficacia ha sido cuestionada debido a la suposición que los quistes morirían espontáneamente, y por lo tanto, las reacciones inflamatorias relacionadas con la terapia son innecesarias. Además, algunos reportes aislados han cuestionado si la neurocisticercosis (NCC) causa epilepsia. Actualmente, existe una gran cantidad de evidencia disponible y existen pocas dudas, si las hay, sobre el rol de la NCC como causa de crisis convulsivas no provocadas. La NCC se asocia con convulsiones cuando se comparan grupos adecuados, y en un grupo considerable de pacientes, la semiología de las convulsiones se correlaciona con la ubicación anatómica de los parásitos. La degeneración de los quistes y la posterior reacción inflamatoria relacionada con la terapia pueden aumentar transitoriamente la expresión de las convulsiones, y esto puede preverse y controlarse con el uso adicional de corticosteroides. Varios estudios controlados y la opinión de la mayoría de los expertos en el tema respaldan el concepto de que la eficacia de los fármacos cisticidas, su seguridad y el impacto de la destrucción de los quistes en la evolución de las crisis convulsivas, superan en gran medida los riesgos potenciales del tratamiento y han proporcionado evidencia del papel de la NCC como causa de ataques recurrentes no provocados (epilepsia).

ABSTRACT Cysticidal drugs have been used for more than three decades. However, its efficacy has been questioned on the assumption that cysts would die spontaneously, and thus, inflammatory reactions related to therapy are unnecessary. In addition, isolated reports have also questioned whether neurocysticercosis (NCC) causes epilepsy. A large body of evidence is currently available and little - if any - doubt exists on NCC as a cause of unprovoked seizures. NCC is consistently associated with seizures when suitable groups are compared, and in a sizable subset of patients, the semiology of seizures correlates with the anatomical location of parasites. Cyst degeneration and the subsequent inflammatory reaction related to therapy may transiently increase seizure expression, and this can be anticipated and managed with the additional use of corticosteroids. Several controlled trial support the concept that cysticidal drug efficacy, safety, and the impact of cyst destruction in decreasing seizures largely overcome the potential risks of therapy, and have provided evidence of the role of NCC as a cause of recurrent unprovoked seizures (epilepsy).

Hepatitis aguda recurrente inducida por albendazol / Recurrent albendazole-induced acute hepatitis

Resumen El albendazol es un medicamento usado para tratar infecciones por helmintos y usualmente presenta pocos o ningún efecto secundario. A pesar de que hay un incremento transitorio de enzimas hepáticas luego de su uso, existe poca evidencia en la literatura en la que se reporte lesión hepática luego de automedicación con albendazol. En este informe, el paciente se presentó con hepatitis aguda luego de automedicarse con albendazol. El paciente cuenta además con una historia de episodios similares después de haber usado el fármaco. Se evaluada la causalidad con el método de evaluación de causalidad de Roussel Uclaf del Concejo para Organizaciones Internacionales de Ciencias Médicas, cuyo resultado fue un puntaje de 10, lo que indicó una alta probabilidad de lesión hepática inducida por albendazol al cabo de realizarse una investigación rigurosa y de excluir otras posibles causas de la condición física del paciente. En conclusión, aunque es ideal agilizar el proceso para combatir a los helmintos, es necesario intensificar la necesidad de monitorizaciones de calidad para evitar reacciones adversas como la hepatitis inducida por medicamentos. Asimismo, la automedicación de cualquier medicamento debe ser siempre evitada.

Abstract Albendazole is used to treat helminth infections and usually has minimal or no side effects. A transient increase in liver enzymes is common following its use, but little evidence of albendazole-induced liver damage has been reported in the literature. This study presents a patient who developed acute hepatitis following self-medication with albendazole. The patient also had a history of similar episodes in the past after using the drug. After a thorough investigation and exclusion of all other causes of the patient's clinical condition, the Roussel Uclaf Causality Assessment Method of the Council for International Organizations of Medical Sciences scale yielded a score of 10 points, indicating a high probability of albendazole-induced liver damage. In conclusion, expediting the process of combating helminths is ideal, but quality monitoring is required to avoid adverse reactions such as drug-induced hepatitis. Moreover, self-medication with any drug should always be discouraged.

Haemonchosis en una ternera raza Brahman en el trópico alto del Nordeste Antioqueño / Haemonchosis in a Brahman calf in the high tropics of the Antioquian Northeast / Hemoncose em uma bezerra raça Brahman no trópico alto do nordeste da Antioquia

Resumen La haemonchosis es una parasitosis que, en bovinos, a diferencia de los pequeños rumiantes, raramente causa mortalidad. No obstante, cargas parasitarias que normalmente son subclínicas en terneros bien alimentados, pueden convertirse en clínicas causando la muerte, cuando la condición corporal es pobre. Este reporte describe un caso de haemonchosis fatal en un ternero Brahman de 7 meses y el resultado del tratamiento con albendazol (10 mg/kg PO) en 17 terneros congéneres. La finca es de cría y levante de ganado de carne y está ubicada en el trópico alto, en el municipio de Yarumal, Antioquia, a una altura de 2.353 m.s.n.m y una temperatura promedio de 14 ºC. En la producción no reportan plan sanitario adicional a la vacunación contra aftosa. El diagnóstico se sospechó inicialmente con base en observaciones clínico-patológicas de una anemia severa con hipoproteinemia de etiología no inflamatoria, y se confirmó en el examen post-mortem por la presencia de cientos de nematodos adultos de Haemonchus spp. en el abomaso, y un recuento de 19.200 huevos por gramo (HPG) de heces de trichostrongylidos. El coprocultivo de heces mostró que el 70, 20, y 10% de dichos huevos pertenecían a especies de Haemonchus, Coperia, y otros géneros de nematodos, respectivamente. El tratamiento con albendazol fue eficaz reduciendo las cargas parasitarias en los 17 terneros tratados desde niveles moderados (200-700 HPG) y altos (>700 HPG), a niveles bajos (16-100 HPG). Se redujo por completo la infección en la mitad de los animales tratados y solo estuvo por debajo del 90% en 3 animales. Debido a que la media del porcentaje de reducción de huevos fue del 95% se deduce que no existe resistencia al albendazol. En conclusión, este caso revela que la haemonchosis en terneros debe incluirse dentro de los diagnósticos diferenciales de mortalidad en el trópico colombiano y la realización de necropsias y exámenes coprológicos periódicos son imprescindibles para poder instaurar medidas preventivas y de control de dichas parasitosis.

Abstract Haemonchosis is a parasitic disease that in cattle, unlike small ruminants, rarely causes mortality. However, parasitic burdens that are usually subclinical in well-fed calves may become clinical causing death when body condition is poor. This report describes a case of fatal haemonchosis in a 7-month-old Brahman calf and the results of treatment with albendazole (10 mg/kg PO) in 17 cohort calves. The farm, dedicated to breeding and rearing beef calves, was located in the high tropics of the Andes, municipality of Yarumal (Antioquia), at 2,353 meters of altitude with an annual mean temperature of 14 °C. Apart from vaccination for foot and mouth disease, the animals are not subjected to any other treatments. The diagnosis was initially suspected based on clinico-pathological observations of a severe anemia with hypoproteinemia of non-inflammatory etiology, and was confirmed in the postmortem examination by the presence of hundreds of adult nematodes of Haemonchus spp. in the abomasum and a count of 19,200 eggs per gram of feces (EPG) of trichostrongylids. Stool culture showed that 70, 20, and 10% of these eggs belonged to Haemonchus, Coperia and other nematode genera, respectively. Albendazole treatment was effective in reducing parasitic loads in 17 treated calves from moderate (200-700 OPG) and high levels (> 700 EPG) to low levels (16-100 EPG). The infection was completely eliminated in half of the treated animals and was reduced to below 90% in only 3 animals. Because the mean egg reduction percentage was 95%, it can be inferred that there is no resistance to albendazole. In conclusion, this case reveals that haemonchosis should be included in the differential diagnosis of mortality in calves in the Colombian tropics, and that necropsies and periodic coprological examinations are necessary to establish preventive and control measures of this parasitosis.

Resumo A hemoncose é uma doença parasitária que no gado, ao contrário dos pequenos ruminantes, raramente causa mortalidade. No entanto, cargas parasitas que geralmente são subclínicas em bezerros bem alimentados, podem tornar-se clinicamente causadores de morte quando a condição corporal é ruim. Este relato descreve um caso de hemoncose fatal em um bezerro Brahman de 7 meses de idade e os resultados do tratamento com albendazol (10 mg/kg PO) em 17 bezerros da coorte. A fazenda, dedicada à criação de bezerras, está localizada no trópico alto dos Andes, município de Yarumal (Antioquia), a 2.353 metros de altitude, com temperatura média anual de 14 ºC. Além da vacinação para a febre aftosa, os animais não são submetidos a outros tratamentos. O diagnóstico foi inicialmente suspeito com base em observações clínico-patológicas de uma anemia grave com hipoproteinemia de etiologia não inflamatória, e foi confirmado no exame post-mortem pela presença de centenas de nematóides adultos de Haemonchus spp. no abomaso e uma contagem de 19.200 ovos por grama de fezes (EPG) de tricostrongilídeos. A cultura de fezes mostrou que 70, 20 e 10% desses ovos pertenciam a Haemonchus, Coperia e outros gêneros de nematóides, respectivamente. O tratamento com albendazol foi eficaz na redução das cargas parasitas em 17 bezerros tratados de níveis moderados (200-700 OPG) e altos (> 700 EPG) para níveis baixos (16-100 EPG). A infecção foi completamente eliminada em metade dos animais tratados e foi reduzida para menos de 90% em apenas 3 animais. Como a porcentagem média de redução de ovos foi de 95%, pode-se inferir que não há resistência ao albendazol. Em conclusão, este caso revela que a hemoncose deve ser incluída no diagnóstico diferencial de mortalidade em bezerros nos trópicos colombianos, e que necropsias e exames coprológicos periódicos são necessários para estabelecer medidas preventivas e de controle desta parasitose.

Metaanálisis: Efectividad del tratamiento a largo y corto plazo con albendazol para la neurocisticercosis intraparenquimatosa / Meta-analysis: Effectiveness of long- and short-term albendazole therapy for intraparenchymal neurocysticercosis

Objetivo: Determinar la efectividad del tratamiento con Albendazol de larga y corta duración en adultos y niños con neurocisticercosis parenquimatosa cística o transicional, verificado por neuroimagen. Materiales y métodos: Un metaanálisis fue realizado analizando los ensayos clínicos de Medline y LILACS con un puntaje de Jadad > 2. Estudios adicionales no fueron identificados en Clinicaltrials.gov y Researchgate. La variable principal fue la persistencia de las lesiones radiológicas y la secundaria los efectos adversos. El RR acumulado y un intervalo de confianza del 95 % fueron calculados para las dos variables usando el modelo de efectos fijos de Mantel-Haenszel. El análisis fue realizado en el programa Stata 11. La heterogeneidad fue evaluada con el prueba chi cuadrado, una p < 0,10 fue considerada estadísticamente significativa. El sesgo de publicación fue evaluado por el análisis de sensibilidad y la prueba de Egger. Resultados: Cuatro estudios fueron incluidos. No hay diferencia entre la terapia de larga y corta duración para la neurocisticercosis. El RR acumulado de la persistencia de lesiones radiológicas después del tratamiento a corto plazo en comparación al de largo plazo fue 1,05 (IC 95 % 0,72-1,54). La prueba de Mantel-Haenszel demostró un valor de p de 0,789. Además, ambos, el análisis de sensibilidad y la prueba de Egger apoyaron la ausencia de sesgo de publicación. No hubo diferencia significativa respecto a los efectos adversos. Conclusiones: La evidencia sugiere que no hay diferencia entre el tratamiento de corto y largo plazo para las lesiones parenquimatosas transicionales únicas, por lo que el tratamiento de corto plazo puede ser usado efectivamente.

Objective: To determine the effectiveness of long- and short-term albendazole therapy in adults and children with cystic and transitional parenchymal neurocysticercosis confirmed by neuroimaging. Materials and methods: A meta-analysis was performed using clinical trials from MEDLINE and LILACS with a Jadad score > 2. Additional studies were not found on ClinicalTrials.gov and ResearchGate. The main endpoint was the persistence of radiological lesions and the secondary endpoint was the presence of adverse effects. Pooled relative risks (RR) and 95 % confidence intervals were calculated for both endpoints using the Mantel-Haenszel fixed-effects model. The analysis was conducted using software Stata 11. Heterogeneity was assessed by chi-square test and a value of p < 0.10 was considered statistically significant. Publication bias was estimated by sensitivity analysis and Egger's test. Results: Four studies were included. There was no difference between long- and short-term albendazole therapies for neurocysticercosis. Pooled RR of the persistence of radiological lesions after short-term vs. long-term therapy was 1.05 (95 % CI 0.72-1.54). Mantel-Haenszel test showed a p-value of 0.789. Moreover, both the sensitivity analysis and Egger's test supported the absence of publication bias. No significant difference was noticed regarding the adverse effects. Conclusions: Evidence suggests that there is no difference between short- and long-term therapies for single transitional parenchymal lesions; therefore short-term therapy may be used effectively.

Equinococosis quística músculo-esquelética primaria de evolución crónica / Primary musculo-skeletal echinococcosis of chronic evolution

Resumen La equinococosis quística es una zoonosis parasitaria crónica de alta prevalencia en Chile. Se presenta el caso clínico de un varón de 66 años, proveniente de la Región del Maule, con una equinococosis quística músculo-esquelética. Consultó por dolor, aumento de volumen y una fístula en muslo izquierdo, con salida de líquido cristalino. En el estudio imagenológico se identificaron múltiples lesiones quísticas en el ala sacra, hueso ilíaco y tejidos blandos de zona inguinal y muslo izquierdo. La serología Elisa IgG para Equinococcus granulosus fue positiva. Se realizó la resección quirúrgica de las lesiones musculares y se inició terapia antiparasitaria combinada con albendazol y praziquantel, con buena respuesta clínica; sin embargo, al suspender la terapia, por iniciativa del paciente, se reiniciaron los síntomas.

Cystic echinococcosis is a chronic parasitic zoonosis of high prevalence in Chile. We report a clinical case of a 66-year-old man, domiciled in an urban area of the Maule Region, who presents skeletal muscle cystic echinococcosis. Consultation for pain, volume increase and left thigh fistula that gives out crystalline fluid. In the study with imaging techniques, multiple cystic lesions are identified in the sacral wing, iliac bone, soft tissues of the groin and left thigh. No cysts were evident in other organs. Serology Elisa IgG was positive Echinococcus granulosus. Surgical resection of soft tissue injuries. Combined antiparasitic therapy with albendazole and praziquantel was started, with good clinical response. Upon discontinuation of antiparasitic therapy at the initiative of the patient, symptoms are reinitiated.

Toward novel antiparasitic formulations: Complexes of Albendazole desmotropes and ß-cyclodextrin.

Novel complexes of two different solid forms of Albendazol and ß-cyclodextrin were investigated in an attempt to obtain promising candidates for the preparation of alternative matrices used in pharmaceutical oral formulations. The interaction between each form of Albendazol and ß-cyclodextrin was studied in solution and solid state, in order to investigate their effect on the solubility and dissolution rate of Albendazol solid forms. The solid supramolecular systems were characterized using a variety of techniques including natural-abundance 13C cross-polarization magic-angle-spinning nuclear magnetic resonance, powder X-ray diffraction, Fourier transform-infrared spectroscopy and scanning electron microscopy. The results obtained showed the highest increment of solubility and dissolution rate, in simulated gastric fluid, for the Albendazole II:ß-cyclodextrin systems. Thus, these new complexes constitute an interesting alternative for improving the oral bioavailability of Albendazol.

Antiparasitic drugs: in vitro tests against nematophagous fungi / Antiparasitários: teste in vitro contra fungos nematófagos

Abstract The use of biological agents has been intensified in recent years against eggs and larvae of gastrointestinal nematodes as an alternative control method in pasture plant health management, with the concomitant use with antiparasitic drugs still occurring. The aim of this study was to test the in vitro activity of the following antiparasitic drugs: Ivermectin and albendazole against the following nematophagous fungi: Paecilomyces fumosoroseus, Paecilomyces lilacinus and Paecilomyces variotii. The agar diffusion test was performed using an initial concentration of 0.0016g/mL of each drug, after solidification of the culture medium containing the drug concentration each nematophagous fungi was inoculated. The results showed that in a concentration of 80μg/mL, the fungal growth decreased, however, with the concentration of 160μg/mL, there was no fungal growth in both drugs, compared to the control, which indicates an inhibition in the development of the nematophagous fungi studied when they come in contact with ivermectin and albendazole.

Resumo O uso de agentes biológicos que atuam em ovos e larvas de nematódeos gastrintestinais como uma alternativa para o manejo de pastagens de saúde tem se intensificado nos últimos anos, bem como o uso concomitante com outros medicamentos antiparasitários. O objetivo deste estudo foi testar o efeito in vitro dos fármacos Ivermectina e Albendazol em fungos nematófagos Paecilomyces fumosoroseus, Paecilomyces lilacinus e Paecilomyces variotii. Foi utilizada a técnica de difusão em agar, sendo preparado a partir de uma concentração inicial de 0,0016g/mL de cada uma das drogas e diluídas em meio de cultura, com posterior semeadura dos fungos nematófagos. Os resultados mostraram que na concentração de 80μg/mL, o crescimento diminuiu, no entanto, com a concentração de 160μg/mL de ambas as drogas, não houve crescimento de fungos durante o período de estudo, em comparação com o controle, indicando a inibição do desenvolvimento dos fungos nematófagos estudados quando em contato com a Ivermectina e Albendazol.